Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
Alina Iovleva, Mustapha M. Mustapha, M. Patrick Griffith, Lauren Komarow, Courtney Luterbach, Daniel R. Evans, Eric Cober, Sandra S. Richter, Kirsten Rydell, César A. Arias, Jesse T. Jacob, Robert A. Salata, Michael J. Satlin, Darren Wong, Robert A. Bonomo, David van Duin, Vaughn S. Cooper, Daria Van Tyne, Yohei Doi
Abstract
Carbapenem-resistant Acinetobacter baumannii (CR Ab ) constitutes a major threat to public health. To elucidate the molecular and clinical epidemiology of CR Ab in the United States, clinical CR Ab isolates were collected along with data on patient characteristics and outcomes, and bacterial isolates underwent whole-genome sequencing and antibiotic susceptibility phenotyping.
Topics & Concepts
Acinetobacter baumanniiAntimicrobialMicrobiologyAntibiotic resistanceCarbapenemAcinetobacterDrug resistanceMedicineBiologyIntensive care medicineVirologyPseudomonas aeruginosaBacteriaAntibioticsGeneticsAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceVibrio bacteria research studies